Skip to content
OpenCapital
Get started

Harmony Biosciences Holdings, Inc. HRMY EBITDA margin

EBITDA margin at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
-10.9%-28.0pp
Alkermes logo
AlkermesALKS
14.8%-12.9pp
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
-23.5%-8.9pp
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-572.1%-593pp
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
8.5%-16.4pp
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
51.2%+0.9pp

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$1.99B-14.9%

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Calculated from Harmony Biosciences Holdings, Inc.’s reported figures.

ebitda/total revenue=23.7%

Based on trailing twelve months.

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s EBITDA margin?
Harmony Biosciences Holdings, Inc. (HRMY) reported EBITDA margin of 23.7% in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s EBITDA margin changed year-over-year?
Harmony Biosciences Holdings, Inc.'s EBITDA margin decreased by 19.3% year-over-year, from 29.4% to 23.7%.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s EBITDA margin?
Over 5 years (2020 to 2025), Harmony Biosciences Holdings, Inc.'s EBITDA margin has grown at a 10.4% compound annual growth rate (CAGR), from 16.3% to 26.8%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.